Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 39

Sort by

Sort Order Select

Journal Articles

Increased Cortical Glycolysis Following CD19 CART Therapy: A Radiographic Surrogate for an Altered Blood-Brain Barrier

Ali Bukhari, MD, Vivek Kesari, MD, Reza Sirous, MD, Noa G. Holtzman, MD, Seung Tae Lee, MD PhD, Natalie Gahres, RN, Elizabeth Hutnick, RN, Kathleen Ruehle, RN, Mehmet Hakan Kocoglu, MD, Ashraf Z. Badros, Jean A. Yared, MD, Nancy M. Hardy, MD, Aaron P. Rapoport, Babak Saboury, MD MPH, Saurabh Dahiya, MD

Blood (2019) 134 (Supplement_1): 4454.

https://doi.org/10.1182/blood-2019-125794

Published: 2019

Journal Articles

Combined Modality Low-Dose Radiation Therapy (2 Gy x 2) and Single-Agent Rituximab Immunotherapy in the Treatment of Indolent Non-Hodgkin Lymphoma

Samantha Brocklehurst, Neil Desai, MD MHS, Jennifer L Shah, MD, Syed Rizvi, MD, Praveen Ramakrishnan Geethakumari, MD, Kiran A Kumar, MD MBA

Blood (2019) 134 (Supplement_1): 5262.

https://doi.org/10.1182/blood-2019-131246

Published: 2019

Journal Articles

Impact of Histologic Type on Survival in Primary Parotid Lymphomas

Taha Al-Juhaishi, MD, Arushi Khurana, MBBS, Danielle Shafer, DO, Victor Yazbeck, MD

Blood (2019) 134 (Supplement_1): 5882.

https://doi.org/10.1182/blood-2019-130981

Published: 2019

Journal Articles

Clinical Significance of Testicular FDG-PET/CT Uptake in Aggressive Lymphomas

Hidong Kim, MD, Laura Harper, MD, Thomas M. Habermann, MD, Grzegorz S. Nowakowski, MD, Carrie A. Thompson, MD, Patrick Johnston, Thomas E. Witzig, MD, Cristine Allmer, BS, Matthew J. Maurer, MS, James R. Cerhan, MD PhD, Jason Young, MD, Gita Thanarajasingam, MD

Blood (2018) 132 (Supplement 1): 5401.

https://doi.org/10.1182/blood-2018-99-117711

Published: 2018

Journal Articles

Secondary Solid Cancer Following Hematopoietic Cell Transplantation in Patients with Thalassemia Major

Alessia Pepe, MD, Antonella Meloni, PhD, Stella Santarone, Annalisa Natale, Mauro Di Ianni, MD PhD, Laura Pistoia, MD, Liana Cuccia, MD, Anna Spasiano, Roberto Lisi, Paolo Di Bartolomeo, MD

Blood (2017) 130 (Supplement 1): 3274.

https://doi.org/10.1182/blood.V130.Suppl_1.3274.3274

Published: 2017

Journal Articles

Clinical Features and Treatment Approaches in Patients with Rosai-Dorfman Disease: The Mayo Clinic Experience

Gaurav Goyal, MBBS, Aishwarya Ravindran, MBBS, Mrinal M. Patnaik, MDMBBS, Grzegorz S Nowakowski, MD, Gita Thanarajasingam, MD, Thomas M Habermann, MD, Taimur Sher, MD, Karen L Rech, MD, David J Inwards, MD, Patrick B Johnston, MD PhD, Robert Vassallo, MD, Sameer A. Parikh, MD, Ronald S. Go, MD

Blood (2017) 130 (Supplement 1): 3573.

https://doi.org/10.1182/blood.V130.Suppl_1.3573.3573

Published: 2017

Journal Articles

Rituximab-Bendamustine in First Line Treatment of Patients with Follicular Lymphoma. Results of Prospective Multicenter Study

Nesterova Ekaterina, MD PhD, Sergey K. Kravchenko, MD PhD, Alla M. Kovrigina, MD PhD, Lubov V. Plastinina, MD PhD, Yana K. Mangasarova, MD PhD, Liliya Gorenkova, PhD, Vladimir Vorobyev, MD PhD, Dmitriy Mariin, Elena A. Baryakh, MD PhD, Yuriy Polyakov, Pervin Zeynalova, MD PhD, Elena Volodicheva, MD, Nataliya Glonina, Valeriy G. Savchenko

Blood (2017) 130 (Supplement 1): 5170.

https://doi.org/10.1182/blood.V130.Suppl_1.5170.5170

Published: 2017

Journal Articles

Bortezomib Combined with Mitoxantrone, Vincristine, Peg-Asparaginase and Dexamethasone for Children with Relapsed Acute Lymphoblastic Leukemia

Keith J August, MD MS, Alan S Gamis, MD MPH, Julia A. Hays, MD, Karen Lewing, MD, Erin Guest, MD

Blood (2017) 130 (Supplement 1): 5039.

https://doi.org/10.1182/blood.V130.Suppl_1.5039.5039

Published: 2017

Journal Articles

Hyper-CVAD Plus Epratuzumab As Salvage Regimen for Younger Relapsed/Refractory CD22+ B Acute Lymphoblastic Leukemia (ALL) Patients: Results of the Phase 2 Prospective Cheprall Study

Blood (2016) 128 (22): 4018.

https://doi.org/10.1182/blood.V128.22.4018.4018

Published: 2016

Journal Articles

Clinical, Biological Characteristics and Outcome of Pediatric Follicular Lymphoma at Children's Cancer Hospital - Egypt: A Single Center Experience

Shaimaa Samir Eissa, MD PhD, Samah Fathy Semary, MD, Asmaa Salama, MD, Alaa M Elhaddad, MD PhD

Blood (2016) 128 (22): 5343.

https://doi.org/10.1182/blood.V128.22.5343.5343

Published: 2016

Journal Articles

Rare Case of Patient with HIV Related Plasmablastic Lymphoma Presenting with Bilateral Parotid Involvement and Hypergammalobulemia

Damien Hansra, MD, Jorge Antunez de Mayolo, MD, Lisellete Morin, MS, PA-C, Frank Aranda, MD, Oscar Herrera, MD, Abelardo Arango, MD, Jason Kosove, MD, Maureen Cioffi-Lavina, MD

Blood (2016) 128 (22): 5320.

https://doi.org/10.1182/blood.V128.22.5320.5320

Published: 2016

Journal Articles

Clinical Features and Prognosis of CD20-Positive Peripheral T-Cell Lymphoma, Not Otherwise Specified (PTCL-NOS) in Chinese Patients: A Retrospective Single Institution Analysis

Shaoxuan Hu, Xiaohui He, MD, Yuankai Shi, MD PhD, Sheng Yang, MD, Yan Qin, MD, Jianliang Yang, MD, Mei Dong, MD, Shengyu Zhou, MD, Peng Liu, MD, Lin Gui, MD, Changgong Zhang, MD, Liqiang Zhou, MD

Blood (2015) 126 (23): 5045.

https://doi.org/10.1182/blood.V126.23.5045.5045

Published: 2015

Journal Articles

AGMT MALT-2: A Phase II Study of Rituximab Plus Lenalidomide in Patients with Extranodal Marginal Zone B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue (MALT lymphoma)

Barbara Kiesewetter, MD, Richard Greil, MD, Wolfgang Willenbacher, MD, Peter Neumeister, MD, Michael A. Fridrik, MD, Raderer Markus, MD

Blood (2015) 126 (23): 3973.

https://doi.org/10.1182/blood.V126.23.3973.3973

Published: 2015

Journal Articles

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) of the Salivary Gland Is Associated with Improved Prognosis When Arising in a Background of Sjögren’s Disease and May Not Benefit from Local Therapy

Amie E Jackson, MD, Michael Mian, Christina H. Kalpadakis, MD, Gerassimos A Pangalis, MD, Anastasios Stathis, MD, Elena Porro, MSc, Ellen D McPhail, MD, Thomas M Habermann, MD, Kay M. Ristow, Franco Cavalli, MD, Grzegorz S. Nowakowski, MD, Emanuele Zucca, MD

Blood (2014) 124 (21): 1637.

https://doi.org/10.1182/blood.V124.21.1637.1637

Published: 2014

Journal Articles

Isolated Granulocytic Sarcoma Of The Nasopharynx: A Case Report and Review Of The Literature

Ravindra Reddy Chuda, MD, Prakash Vishnu, MD, FACP, Dick Hwang, MD, Ph.D, David M. Aboulafia, MD

Blood (2013) 122 (21): 5010.

https://doi.org/10.1182/blood.V122.21.5010.5010

Published: 2013

Journal Articles

Cytogenetic and Molecular Characterization of Extramedullary Disease (EMD) in Patients (pts) with Acute Myeloid Leukemia (AML).

Naveen Pemmaraju, M.D., Hagop M. Kantarjian, MD, Kathy M. Tran, Syed M. Kazmi, MD, Tapan M. Kadia, M.D., Gautam Borthakur, M.D., Srdan Verstovsek, MD, PhD, Susan O'Brien, MD, Guillermo Garcia-Manero, MD, Zeev Estrov, MD, PhD, Stefan Faderl, MD, Farhad Ravandi, MD, Sherry A. Pierce, RN, BS, Jorge E. Cortes, MD, Alfonso Quintas-Cardama, MD

Blood (2012) 120 (21): 2592.

https://doi.org/10.1182/blood.V120.21.2592.2592

Published: 2012

Journal Articles

Treatment of Burkitt's Like Lymphoma: A Single Institution Case Series

Vishal Ranpura, MD, Shilpan S. Shah, MD

Blood (2011) 118 (21): 4962.

https://doi.org/10.1182/blood.V118.21.4962.4962

Published: 2011

Journal Articles

Patients with Limited Stage Extranodal Marginal Zone Lymphoma Have Excellent Overall Survival Regardless of Choice of Therapy Type or Observation

Sarah C. Rutherford, MD, Wayne Tam, MD, PhD, Richard R. Furman, MD, Rebecca Elstrom, MD, Jia Ruan, MD, PhD, Morton Coleman, MD, John P. Leonard, MD, Peter Martin, MD

Blood (2011) 118 (21): 1579.

https://doi.org/10.1182/blood.V118.21.1579.1579

Published: 2011

Journal Articles

Primary Parotid MALT Lymphoma: Clinical Characteristics and Treatment – a Single Institution Experience

Jason M. Jones, MD, Thomas M. Habermann, MD, Kay M. Ristow, Paul Kurtin, MD, Ellen McPhail, MD, Carrie A. Thompson, MD, Joseph P. Colgan, MD, Luis F. Porrata, MD, Svetomir N. Markovic, MD, PhD, Thomas E. Witzig, MD, James A. Martenson, Jr., MD, Grzegorz S. Nowakowski, MD

Blood (2011) 118 (21): 1580.

https://doi.org/10.1182/blood.V118.21.1580.1580

Published: 2011

Journal Articles

Efficacy of Intrathecal Rituximab In the Management of CNS Relapse of Aggressive HIV Related Lymphoma

Suthanthira Kannan Ramamoorthy, MD, FRCPA, Vishnu Kumar, R Scientist, Jr.

Blood (2010) 116 (21): 4929.

https://doi.org/10.1182/blood.V116.21.4929.4929

Published: 2010

NARROW

Increased Cortical Glycolysis Following CD19 CART Therapy: A Radiographic Surrogate for an Altered Blood-Brain Barrier

Combined Modality Low-Dose Radiation Therapy (2 Gy x 2) and Single-Agent Rituximab Immunotherapy in the Treatment of Indolent Non-Hodgkin Lymphoma

Impact of Histologic Type on Survival in Primary Parotid Lymphomas

Clinical Significance of Testicular FDG-PET/CT Uptake in Aggressive Lymphomas

Secondary Solid Cancer Following Hematopoietic Cell Transplantation in Patients with Thalassemia Major

Clinical Features and Treatment Approaches in Patients with Rosai-Dorfman Disease: The Mayo Clinic Experience

Rituximab-Bendamustine in First Line Treatment of Patients with Follicular Lymphoma. Results of Prospective Multicenter Study

Bortezomib Combined with Mitoxantrone, Vincristine, Peg-Asparaginase and Dexamethasone for Children with Relapsed Acute Lymphoblastic Leukemia

Hyper-CVAD Plus Epratuzumab As Salvage Regimen for Younger Relapsed/Refractory CD22+ B Acute Lymphoblastic Leukemia (ALL) Patients: Results of the Phase 2 Prospective Cheprall Study

Clinical, Biological Characteristics and Outcome of Pediatric Follicular Lymphoma at Children's Cancer Hospital - Egypt: A Single Center Experience

Rare Case of Patient with HIV Related Plasmablastic Lymphoma Presenting with Bilateral Parotid Involvement and Hypergammalobulemia

Clinical Features and Prognosis of CD20-Positive Peripheral T-Cell Lymphoma, Not Otherwise Specified (PTCL-NOS) in Chinese Patients: A Retrospective Single Institution Analysis

AGMT MALT-2: A Phase II Study of Rituximab Plus Lenalidomide in Patients with Extranodal Marginal Zone B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue (MALT lymphoma)

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) of the Salivary Gland Is Associated with Improved Prognosis When Arising in a Background of Sjögren’s Disease and May Not Benefit from Local Therapy

Isolated Granulocytic Sarcoma Of The Nasopharynx: A Case Report and Review Of The Literature

Cytogenetic and Molecular Characterization of Extramedullary Disease (EMD) in Patients (pts) with Acute Myeloid Leukemia (AML).

Treatment of Burkitt's Like Lymphoma: A Single Institution Case Series

Patients with Limited Stage Extranodal Marginal Zone Lymphoma Have Excellent Overall Survival Regardless of Choice of Therapy Type or Observation

Primary Parotid MALT Lymphoma: Clinical Characteristics and Treatment – a Single Institution Experience

Efficacy of Intrathecal Rituximab In the Management of CNS Relapse of Aggressive HIV Related Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only